Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep

Critical Care Medicine

Volumn 24, Issue 11, 1996, Pages 1841-1848

  Booke, Michael ^a   Bradford, Darien W ^a   Hinder, Frank ^a   Harper, Donald ^a   Brauchle, Randall W ^a   Traber, Lillian D ^a   Traber, Daniel L ^b,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

adult respiratory distress syndrome; cardiac output; eicosanoids; hypoxia; lung; lung injury; prostaglandins; pulmonary emergencies; pulmonary hypertension; pulmonary vasoconstriction; sheep

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ARTICLE; HYPOXIA; LUNG BLOOD FLOW; LUNG VENTILATION PERFUSION RATIO; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHEEP;

ADMINISTRATION, INHALATION; ANESTHESIA; ANIMALS; EPOPROSTENOL; FEMALE; HEMODYNAMIC PROCESSES; LUNG; NEBULIZERS AND VAPORIZERS; NITRIC OXIDE; PULMONARY CIRCULATION; PULMONARY GAS EXCHANGE; SHEEP; VASOCONSTRICTION;

EID: 0029806092     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199611000-00014     Document Type: Article

References (28)

1. Lückhoff A, Pohl U, Mülsch A, et al: Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol 1988; 95: 189-196
2. Isaacson TC, Hampl V, Weir EK, et al: Increased endothelium-derived nitric oxide in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol 1994; 76:933-940
3. Gryglewski RJ: Interactions between nitric oxide and prostacyclin. Semin Thromb Hemost 1993; 19:158-166
4. Gryglewski RJ, Botting RM, Vane JR: Mediators produced by the endothelial cell. Hypertension 1988; 12:530-548
5. Fratacci MD, Frostell CG, Chen TY, et al: Inhaled nitric oxide. Anesthesiology 1991; 75:990-999
6. Jolin A, Bjertnas L: Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndrome. Acta Anaesthesiol Scand 1991; 35:40-51
7. Radermacher P, Santak B, Wüst HJ, et al: Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 1990; 16:227-232
8. Perlman MB, Lo SK, Malik AB: Effect of prostacyclin on pulmonary vascular response to thromhin in awake sheep. J Appl Physiol 1986; 60:546-553
9. Clarke C: Prostacyclin infusion in ARDS. Anesthesiology 1990; 73:194-195
10. 2. J Appl Physiol 1978; 45:408-413
11. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:2038-2047
12. Frostell CG, Blomqvist H, Hedenstierna G, et al: Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78:427-435
13. Pison U, Lopez FA, Heidelmeyer CF, et al: Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993; 74:1287-1292
14. Gerlach H, Pappert D, Lewandowski K, etal: Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19:443-149
15. Radermacher P, Santak B, Wüst HJ, et al: Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 1994; 72:238-244
16. Quinn AC, Vallance P: Inhaled nitric oxide - From pollutant to patent. Eur J Clin Invest 1993; 23:445-447
17. Weite M, Zwissler B, Habazettl H, et al: Prostacyclin aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1994; 25:329-340
18. Gerlach H, Rossaint R, Pappert D, et al: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502
19. Parker JC, Hernandez LA, Peevy KJ: Mechanisms of ventilator-induced lung injury. Crit Care Med 1993; 21:131-143
20. Hickling KG, Henderson SJ, Jackson R: Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16:372-377
21. 2. Lancet 1980; ii:292-294
22. Zapol WM, Snider M, Schneider R: Extracorporeal membrane oxygenation for acute respiratory failure. Anesthesiology 1977; 46:272-285
23. Rovira I, Chen TY, Winkler M, et al: Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 1994; 76:345-355
24. Ewalenko P, Stefanidis C, Holoye A, et al: Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: Effects of propofol and isoflurane. J Appl Physiol 1993; 74:2188-2193
25. Park WK, Lynch C, Johns RA: Effect of propofol and thiopental in isolated rat aorta and pulmonary artery. Anesthesiology 1992; 77:956-963
26. O'Riodan TG, Greco MJ, Perry RJ, et al: Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992; 145:1117-1122
27. Day RW, Guarin M, Lynch JM, et al: Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Crit Care Med 1996; 24:215-221
28. Wilcox DT, Glick PL, Karamanoukian HL, et al: Perfluorocarbon-associated gas exchange improves pulmonary mechanics, oxygenation, ventilation, and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia lamb model. Crit Care Med 1995; 23:1858-1863